m+Medelevator.RU
← Поиск публикаций
MedComm · 2026

Organoids: Current Applications and Future Directions.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Leng Yueqi, Wang Yue, Cao Canhui, Deng Feng, Lian Weisi, Chen Xingtong, Lin Mingmei, Zeng Zhonghong, Mo Dan, Li Shangqi, He Yilei, Yu Yang, Pan Heng, Zhou Ping, Li Rong

Аннотация

Organoids are three-dimensional multicellular structures derived from stem cells or primary tissues that recapitulate key structural and functional features of native organs. Advances in stem cell biology, biomaterials, and bioengineering have established organoids as powerful platforms for studying human development and disease mechanisms, drug discovery, precision medicine, and regenerative medicine. However, current organoid models are limited by incomplete maturation, insufficient vascularization, inadequate immune and neural integration, and poor reproducibility, restricting their physiological relevance and clinical translation. Moreover, the rapid expansion of organoid research has created a need for an updated synthesis of the technological advances, biological applications, and remaining challenges. This review provides a comprehensive overview of organoid technology, covering strategies for organoid generation, including cell sources, three-dimensional culture systems, extracellular matrix support, and microenvironment engineering, followed by representative applications of brain, retinal, kidney, cardiac, lung, liver, intestinal, and endometrial organoids. We further discuss current technical bottlenecks and highlight emerging solutions, including organ-on-chip platforms, multiorgan integration, multiomics, clustered regularly interspaced short palindromic repeats(CRISPR)-based engineering, artificial intelligence, standardized biobanks, and clinical translation. By integrating recent advances across diverse organoid systems, this review provides a framework for developing more physiologically relevant and clinically translatable organoid models.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты